GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LadRx Corp (STU:CX5) » Definitions » Price-to-Funds-From-Operations

LadRx (STU:CX5) Price-to-Funds-From-Operations : (As of May. 16, 2024)


View and export this data going back to 1986. Start your Free Trial

What is LadRx Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


LadRx (STU:CX5) Business Description

Industry
Traded in Other Exchanges
Address
11726 San Vicente Boulevard, Suite 650, Los Angeles, CA, USA, 90049
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.